Janson George / Shutterstock.com
A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
The claim, filed September 30 at the US District Court for the Northern District of California, alleges that Illumina is using a number of gene sequencers which infringe a patent (US number 9,944,984) owned by BGI’s US-based subsidiary, Complete Genomics.
The allegedly infringing sequencers are NovaSeq 6000, HiSeq X Ten, HiSeq 3000, and HiSeq 4000.
According to the filing, the patent covers BGI's proprietary “patterned array” technology. BGI said its “patterned array” technology is one of the underlying technologies for high-throughput, high-quality gene sequencing.
The company is seeking damages and an injunction which would require Illumina to stop selling the products.
The counter claim comes after Illumina sued BGI and its US affiliate Complete Genomics for patent infringement on September 18. Illumina alleged that the groups were infringing two of its patents (US numbers 7,566,537 and 9,410,200) for its DNA sequencing technology.
Illumina said BGI had started its commercialisation of the technology in China, outside the reach of US patent law, but was now importing its alleged infringing sequencers into the US.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
BGI, Illumina, genome sequencing, patent infringement, Complete Genomics, US, China, DNA